These limitations notwithstanding, our data reinforce the notion that TREM2 plays an important role in AD, shed some light on the mechanisms responsible for its regulation, and suggest that TREM2 measurement in peripheral blood could be a useful biomarker for AD diagnosis and prognosis. The gene discussed is TREM2; the disease is Alzheimer disease.